Section
Policy
IRA, state PBM reform, Medicare, and regulatory action
PolicyBriefing
Regeneron’s deal makes all 17 drugmakers targeted under the Trump administration’s MFN drug pricing drive comp…
![<![CDATA[Contributor: Prior Authorization in 2026—CMS Is Rebuilding the Operating Model]]>](https://healthcare-images.dcutler.workers.dev/images/article-images/cdata-contributor-prior-authorization-in-2026-cms-is-rebuild.png)
PolicySTAT News ↗
A Utah pilot to renew prescriptions using a bot faced backlash from the state's medical board, which called fo…
PolicyPharmaVoice ↗
Debate about drug costs erupted among prominent healthcare figures, including Dr. Oz, Mark Cuban, Calley Means…
PolicyDrug Channels ↗
By Bryce Platt, PharmD Minnesota’s new 340B data reveal a growing disconnect between the program’s size and th…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.